Longitudinal analysis of adaptive immunity following additional SARS-CoV-2 vaccination in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators

Sabatino, J.; Mittl, K.; Rowles, W.; Zamecnik, C.; Loudermilk, R.; Gerungan, C.; Spencer, C.; Sagan, S.; Alexander, J.; McPolin, K.; Deshpande, C.; Wyse, K.; Maeise, E. M.; Wilson, M.; Zamvil, S.; Bove, R.

Sabatino, J.; Mittl, K.; Rowles, W.; Zamecnik, C.; Loudermilk, R.; Gerungan, C.; Spencer, C.; Sagan, S.; Alexander, J.; McPolin, K.; Deshpande, C.; Wyse, K.; Maeise, E. M.; Wilson, M.; Zamvil, S.; Bove, R..

Multiple Sclerosis Journal ; 28(1_SUPPL):85-85, 2022.

Article in English | Web of Science | ID: covidwho-1866090

Keywords

Neurosciences & Neurology

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Prognostic study Topics: Vaccines Language: English Journal: Multiple Sclerosis Journal Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML